Business
Britain goes on COVID-19 vaccine spending spree – The Australian Financial Review
The race is heating up among rich nations eager to get hold of stocks of as-yet unproven vaccines.
The US has booked 300 million of AstraZeneca’s first billion doses, and last week nailed a $US1.95 billion ($2.7 billion) deal with Pfizer for 100 million doses, with an option to secure an additional 500 million doses.
And the European Union is in talks with at least half a dozen developers, including Pfizer, Sanofi and Johnson & Johnson, but Reuters has reported this week that haggling continues over the price, payment method and potential liability costs.
Countries have a duty to protec…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News20 hours agoPolice to get on-the-spot protection powers for DV victims
-
Noosa News16 hours agoBrisbane Doctor jailed for supplying drugs worth millions to bikies
-
General8 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening